Advertisement

Topics

Dr. Reddy's Out-Licenses Plaque Psoriasis Drug to Encore Dermatology

10:11 EDT 22 Aug 2017 | PharmPro

Dr. Reddy's Laboratories announces the out-licensing of DFD-06 to Encore Dermatology. Under the terms of the agreement, Encore will be responsible for the commercialization of DFD-06 in the United States.
Contributed Author: 
Dr. Reddy’s Laboratories Ltd.
Topics: 

Original Article: Dr. Reddy's Out-Licenses Plaque Psoriasis Drug to Encore Dermatology

NEXT ARTICLE

More From BioPortfolio on "Dr. Reddy's Out-Licenses Plaque Psoriasis Drug to Encore Dermatology"

Quick Search
Advertisement
 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Dermatology
Acne Dermatology Eczema Psoriasis Wound Care Dermatology is the medical specialty concerned with the diagnosis and treatment of skin disorders (Oxford Medical Dictionary). As well as studying how the skin works, dermatology covers...